{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:23:19Z","timestamp":1791217399793,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.phrs.2015.07.008","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T01:20:51Z","timestamp":1437182451000},"page":"329-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":180,"special_numbering":"C","title":["Statin therapy and plasma coenzyme Q10 concentrations\u2014A systematic review and meta-analysis of placebo-controlled trials"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-6874","authenticated-orcid":false,"given":"Maciej","family":"Banach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3352-0398","authenticated-orcid":false,"given":"Corina","family":"Serban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin","family":"Ursoniu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Rysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Muntner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredi","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Glasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri P.","family":"Mikhailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2015.07.008_bib0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10545-014-9749-9","article-title":"Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency","volume":"38","author":"Desbats","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.phrs.2015.07.008_bib0010","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1016\/j.mito.2007.02.005","article-title":"Coenzyme Q 10 in cardiovascular disease","volume":"7","author":"Pepe","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.phrs.2015.07.008_bib0015","doi-asserted-by":"crossref","first-page":"25734","DOI":"10.1074\/jbc.273.40.25734","article-title":"A ubiquinone-binding site regulates the mitochondrial permeability transition pore","volume":"273","author":"Fontaine","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2015.07.008_bib0020","first-page":"35","article-title":"CoQ 10 in heart failure and ischemic heart disease","author":"Ayer","year":"2015","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.phrs.2015.07.008_bib0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02592449","article-title":"Exogenous CoQ10 preserves plasma ubiquinone levels in patients treated with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors","volume":"24","author":"Bargossi","year":"1994","journal-title":"Int. J. Clin. Lab. Res."},{"key":"10.1016\/j.phrs.2015.07.008_bib0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.5114\/aoms.2010.14461","article-title":"Effects of coenzyme Q10 supplementation on activities of selected antioxidative enzymes and lipid peroxidation in hypertensive patients treated with indapamide. A pilot study","volume":"6","author":"K\u0119dziora-Kornatowska","year":"2010","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.phrs.2015.07.008_bib0035","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.biocel.2004.11.017","article-title":"10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells","volume":"37","author":"Groneberg","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.phrs.2015.07.008_bib0040","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/S0021-9258(18)99728-0","article-title":"The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol","volume":"241","author":"Mellors","year":"1966","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2015.07.008_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/aoms.2015.49807","article-title":"Statin intolerance\u2014an attempt at a unified definition. Position paper from an International Lipid Expert Panel","volume":"11","author":"Banach","year":"2015","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.phrs.2015.07.008_bib0050","first-page":"16","article-title":"Coenzyme Q10 and statin-induced mitochondrial dysfunction","volume":"10","author":"Deichmann","year":"2010","journal-title":"Ochsner J."},{"issue":"6","key":"10.1016\/j.phrs.2015.07.008_bib0055","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1517\/14740338.2015.1039980","article-title":"Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel","volume":"14","author":"Banach","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.phrs.2015.07.008_bib0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.coph.2007.12.010","article-title":"New insights into mechanisms of statin-associated myotoxicity","volume":"8","author":"Sirvent","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.phrs.2015.07.008_bib0065","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.bcp.2011.01.022","article-title":"Statin or fibrate chronic treatment modifies the proteomic profile of rat skeletal muscle","volume":"81","author":"Camerino","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"17","key":"10.1016\/j.phrs.2015.07.008_bib0070","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy\u2014European Atherosclerosis society consensus panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2015.07.008_bib0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mayocp.2014.08.021","article-title":"Effects of coenzyme Q10 on statin-induced myopathy","volume":"90","author":"Banach","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.phrs.2015.07.008_bib0080","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2007.02.049","article-title":"The role of coenzyme Q10 in statin-associated myopathy: a systematic review","volume":"49","author":"Marcoff","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2015.07.008_bib0085","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clinbiochem.2007.03.016","article-title":"Mevalonate pathway: a review of clinical and therapeutical implications","volume":"40","author":"Buhaescu","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.phrs.2015.07.008_bib0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0891-5849(00)00307-5","article-title":"Regulation of ubiquinone metabolism","volume":"29","author":"Dallner","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2015.07.008_bib0095","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2015.07.008_bib0100","series-title":"Comprehensive Meta-analysis Version 2","first-page":"104","author":"Borenstein","year":"2005"},{"key":"10.1016\/j.phrs.2015.07.008_bib0105","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.phrs.2015.07.008_bib0110","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1089\/dna.2012.1947","article-title":"Does PPAR\u03b32 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis","volume":"32","author":"Sahebkar","year":"2013","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.phrs.2015.07.008_bib0115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ptr.5045","article-title":"Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a Meta-analysis","volume":"28","author":"Sahebkar","year":"2014","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2015.07.008_bib0120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.phrs.2015.07.008_bib0125","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ijcard.2009.12.028","article-title":"Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study","volume":"146","author":"Ashton","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2015.07.008_bib0130","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jama.287.5.598","article-title":"Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial","volume":"287","author":"Jula","year":"2002","journal-title":"Jama"},{"key":"10.1016\/j.phrs.2015.07.008_bib0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0009-8981(01)00549-6","article-title":"Effect of atorvastatin on LDL oxidation and antioxidants in normocholesterolemic type 2 diabetic patients","volume":"311","author":"Oranje","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.phrs.2015.07.008_bib0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","article-title":"High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial","volume":"78","author":"P\u00e4iv\u00e4","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2015.07.008_bib0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2004.10.009","article-title":"Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure","volume":"179","author":"Strey","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2015.07.008_bib0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/j.1552-4604.1993.tb03948.x","article-title":"Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study","volume":"33","author":"Ghirlanda","year":"1993","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2015.07.008_bib0155","unstructured":"Green S., Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011."},{"key":"10.1016\/j.phrs.2015.07.008_bib0160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.phrs.2015.03.009","article-title":"Lipids, blood pressure and kidney update 2014","volume":"95\u201396C","author":"Banach","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2015.07.008_bib0165","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.mayocp.2015.01.003","article-title":"Lipid, blood pressure meta-analysis collaboration G. In reply\u2013coenzyme Q10 and statin-induced myopathy","volume":"90","author":"Banach","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.phrs.2015.07.008_bib0170","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1016\/j.mito.2007.03.002","article-title":"10 and statins: biochemical and clinical implications","volume":"7","author":"Littarru","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.phrs.2015.07.008_bib0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000362390","article-title":"Biochemical diagnosis of coenzyme q10 deficiency","volume":"5","author":"Yubero","year":"2014","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.phrs.2015.07.008_bib0180","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jacc.2012.09.036","article-title":"Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance","volume":"61","author":"Larsen","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2015.07.008_bib0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF02576234","article-title":"Effects of HMG-CoA reductase inhibitors on skeletal muscles of rabbits","volume":"193","author":"Fukami","year":"1993","journal-title":"Res. Exp. Med."},{"key":"10.1016\/j.phrs.2015.07.008_bib0190","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/biof.5520090237","article-title":"CoQ10: could it have a role in cancer management?","volume":"9","author":"Hodges","year":"1999","journal-title":"BioFactors"},{"key":"10.1016\/j.phrs.2015.07.008_bib0195","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1186\/cc10343","article-title":"Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shock","volume":"15","author":"Donnino","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.phrs.2015.07.008_bib0200","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11883-007-0050-3","article-title":"Statin myopathy: incidence, risk factors, and pathophysiology","volume":"9","author":"Sewright","year":"2007","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.phrs.2015.07.008_bib0205","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.2522\/ptj.20090251","article-title":"Effects of statins on skeletal muscle: a perspective for physical therapists","volume":"90","author":"Di Stasi","year":"2010","journal-title":"Phys. Ther."},{"key":"10.1016\/j.phrs.2015.07.008_bib0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/biof.5520180212","article-title":"The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications","volume":"18","author":"Langsjoen","year":"2003","journal-title":"BioFactors"},{"key":"10.1016\/j.phrs.2015.07.008_bib0215","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/JCP.0000000000000097","article-title":"Coenzyme Q10 regulates serotonin levels and depressive symptoms in fibromyalgia patients: results of a small clinical trial","volume":"34","author":"Alcocer-G\u00f3mez","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.phrs.2015.07.008_bib0220","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/sj.mp.4000963","article-title":"Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain","volume":"7","author":"Bauer","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2015.07.008_bib0225","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.clinbiochem.2008.06.012","article-title":"ATP, calcium and magnesium levels in platelets of patients with primary fibromyalgia","volume":"41","author":"Bazzichi","year":"2008","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.phrs.2015.07.008_bib0230","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.2174\/13816128113196660678","article-title":"Statins and new-onset diabetes","volume":"20","author":"Barylski","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2015.07.008_bib0235","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.2174\/1381612811319270014","article-title":"Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevance","volume":"19","author":"Banach","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2015.07.008_bib0240","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/archinternmed.2012.1240","article-title":"Statins and the risk of diabetes: the debate","volume":"172","author":"Katsiki","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.phrs.2015.07.008_bib0245","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.amjcard.2007.12.005","article-title":"Coenzyme Q10 depletion: etiopathogenic or predisposing factor in statin associated myopathy","volume":"101","author":"Chatzizisis","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2015.07.008_bib0250","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2008.05.021","article-title":"Molecular basis of statin-associated myopathy","volume":"202","author":"Vaklavas","year":"2009","journal-title":"Atherosclerosis"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661815001413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661815001413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T13:07:05Z","timestamp":1652879225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661815001413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":50,"alternative-id":["S1043661815001413"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2015.07.008","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin therapy and plasma coenzyme Q10 concentrations\u2014A systematic review and meta-analysis of placebo-controlled trials","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2015.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}